Hyun Joon Kim
Molecular Biology · with Bahar · 2023
A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 70 citations into it
- Epidemiology — 16 citations into it
- Cell Biology — 14 citations into it
- Pathology and Forensic Medicine — 7 citations into it
Whom Hyun Joon Kim trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Hyun Joon Kim's perspective
Ordered by how strongly the researchers Hyun Joon Kim trusts endorse each paper. Same corpus, a different order for every researcher.
- Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
- Coordinating ERK/MAPK signalling through scaffolds and inhibitors (Nature reviews. Molecular cell biology)
- Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
- Ras oncogenes: split personalities (Nature reviews. Molecular cell biology)
- RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF (Nature)
- Autophagy: process and function. (Genes & Development)
- Differential regulation and properties of MAPKs (Oncogene)
- Autophagy and the integrated stress response (Molecules and Cells)
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth (Nature)
- Pathological roles of MAPK signaling pathways in human diseases. (Biochimica et Biophysica Acta)
Their papers
- Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies (2023) — 754 citations